Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Market closed
Gap at. 0033ish filled
Wishing it was Monday also, me too. This is one of those stocks.
Was thinking the same thing.
You called?, lol.
And that one didn't have govt funding, if I remember correctly.
I've been in a few pharmas and I'm liking the stability and future of RSPI the most.
Thanks oldstocks. Nice find!
Still agreeing with you on this one.
I agree. I feel better with rspi than the rgb. P
Same here
Thanks Zino! Glty
Thanks fly! Appreciate the info. Dumped my screenshot of rgbp a while back. Was figuring rgbp had 6x the amount of shares.
Was there for that one.
If I remember correctly Rspi has a "better" share structure than regen.
Looking forward to the possibilities here.
Yeet! :)
Agreed. All we need is Taps to play, though propanc is Australian.
Crickets, lol
Yw Zim
We intend to
seek and identify potential licensees based on the
initial efficacy data from Phase II clinical trials. To accomplish this objective, we have
commenced discussions with potential partners
in our current preclinical phase of development.
Just some interesting stuff from POS.... Propanc Biopharma is collaborating
with
contract research organizations, manufacturing
partners and consultants to complete activities
prior to preparing the CTA for the Phase Tb study.
Welcome Mutat. Only seen you and another here from rgb..p
Thanks Jack
Can I hold you to your word?
Promise?
IKR? Noticed that too
From otc market website regarding onph mentioning rgbp.
2. Current status as a non-shell company: I am of the opinion that ONPH is not currently a
shell company based upon the following:
a. The 2022 Annual Reports reveal that ONPH is engaged in the business of licensing,
developing, manufacturing and commercializing therapeutics.
b. ONPH, per an agreement with Sybleu Therapeutics, has been granted an exclusive world?wide license to develop its cancer therapy. ONPH has also been granted a license by
NanoSmart Pharmaceuticals Inc. for its "novel" drug delivery platform targeting many
types of cancer and other diseases. ONPH has also been granted a license by KCL
Therapeutics Inc., a wholly owned subsidiary of Regen Biopharma to develop a treatment
for human colon cancer; and a license with Ribera Solutions to develop its clinical trial
patient retention app.
c. ONPH is currently engaged in an active trade or business.
d. For the fiscal year ended March 31, 2022 Annual report, cash constitutes less than 2.5%
of total assets.
e. For the fiscal year ended March 31, 2022, ONPH reported operating expenses (exclusive
of depreciation expense) of $61,201.00. ONPH also made investments in licensing
agreements with NanoSmart Pharmaceuticals for $351,350, KCL Therapeutics for
$1,400,000; Regen Biopharma $55,000; and Ribera Solutions $75,000. These operations
and investments demonstrate greater than nominal operations for a company in this stage
of development. The financial statements of ONPH are consistent with an operating
business.
Thanks thug
Looked yesterday, there was nothing, only mention with Rgbp. Googled this am and there is much more info than yesterday.
Yeah and who is Coventry? About as much info on them as Canary.
And a huge difference in outstanding shares
Right!?
I've seen too many people not understand market cap when comparing rgbp to others.
Just found this. Havent read..... https://www.sec.gov/edgar/browse/?CIK=1818674
I hope we are holding aces!
Nice find.